CompuMed, Inc.
CMPD
$3.00
-$0.80-21.05%
| Weiss Ratings | CMPD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | CMPD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | CMPD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.85 | |||
| Price History | CMPD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -21.05% | |||
| 30-Day Total Return | 9.49% | |||
| 60-Day Total Return | -35.07% | |||
| 90-Day Total Return | -1.96% | |||
| Year to Date Total Return | -21.26% | |||
| 1-Year Total Return | 68.54% | |||
| 2-Year Total Return | 9.09% | |||
| 3-Year Total Return | -45.33% | |||
| 5-Year Total Return | -49.98% | |||
| 52-Week High % Change | -36.17% | |||
| 52-Week Low % Change | 102.70% | |||
| Price | CMPD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $4.70 | |||
| 52-Week Low Price | $1.48 | |||
| 52-Week Low Price (Date) | Apr 19, 2024 | |||
| 52-Week High Price (Date) | Nov 20, 2024 | |||
| Valuation | CMPD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.97M | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -- | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $3.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | CMPD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | -- | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CMPD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 310 258 5000 | |||
| Address | 5777 West Century Boulevard Los Angeles, CA 90045 | |||
| Website | www.compumed.net | |||
| Country | United States | |||
| Year Founded | 1973 | |||
| Profitability | CMPD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | CMPD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | CMPD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -- | |||
| Net Income Avl. to Common (TTM) | -- | |||
| Total Revenue Growth (Q YOY) | 1.42% | |||
| Earnings Growth (Q YOY) | 68.49% | |||
| EPS Diluted (TTM) | -- | |||
| EPS Diluted Growth (Q YOY) | 69.06% | |||
| Balance Sheet | CMPD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 4.00K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 370.00K | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | 127.00K | |||
| Current Ratio (Q) | 1.054 | |||
| Book Value Per Share (Q) | -- | |||
| Total Assets (Q) | -- | |||
| Total Current Liabilities (Q) | 351.00K | |||
| Total Debt (Q) | -- | |||
| Total Liabilities (Q) | -- | |||
| Total Common Equity (Q) | 126.00K | |||
| Cash Flow | CMPD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -- | |||
